Clinical Trial Search

Primary: Percentage of Days Used Drugs or Alcohol — 18; 21; 6; 7 percentage of days — p=0.88

Primary: Number of Participants With Drug Use at 3 Months — 49; 48 participants

Primary: Opioid Use Disorder (OUD) and Other Substance Use Disorder (SUD) Treatment Linkage/Retention — -1.5; -8.8 Percentage of days

Primary: Number of Participants With Negative Urinalysis for Alcohol Metabolite (EtG) — 44 Participants

Primary: Number of Participants Abstinent From Marijuana for the 7 Days Prior to Delivery — 6; 7; 6; 3 Participants

Primary: Alcohol Use — 1.37; 0.92 units on a scale

Primary: Fetal Heart Rate — 142.34 beats per minute

Primary: Prevalence of Smoking ≥ 10 Cigarettes/Day in Each Group at Final Measurement by Exhaled Carbon Monoxide Level — 22; 16 participants — p=0.06

Primary: Fetal Heart Rate — 145.7; 143.3; 138.6; 136.3 beats per minute — p=0.001

Primary: Cravings — 11.90; 8.94; 11.10; 8.21 score on a scale (total score, 0 to 30) — p=0.12

Primary: Fetal Heart Rate at 24 Weeks — 143.64 beats per minute

Primary: Child's Head Circumference Measurement (Measured at Birth) — 33.0; 33.8 cm

Primary: Number of Participants With Adolescent and Parent Reported Alcohol, Drug, Vaping and Tobacco Usage — 1; 1; 0; 425 Participants

Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants

Primary: Treatment Completion — 43; 31 Number of women — p=<0.05

Primary: Number of Participants Who Self-reported Retention in Medication Treatment for Opioid Use Disorder — 2 participants who reported 'yes' to MOUD

Primary: Change in the Number of Cigarettes Smoked Per Day — 0; 0 cigarettes per day

Primary: Change in Proportion of Days Used Outside of Controlled Environment — .27; .35; .35; .32 proportion of days used — p=.12

Primary: Urine Ethylglucuronide (EtG) Testing — 0 Participants

Primary: Diagnostic and Statistical Manual-5 (DSM-5) Alcohol Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview…

Primary: Maternal Capacity for Reflective Functioning (Assessed With the Parent Development Interview) — 3.59; 3.08; 3.54; 3.47 units on a scale

Primary: Change in Delay Discounting 5 Trial Adjusted Measure — -3.87; -5.03 log (k) — p=.124

Primary: Child Urine Cotinine — 1.00; .97; 1.09; 1.00 log transformed ng/mL

Primary: Change in the Alcohol Use Disorders Identification Test (AUDIT) Score Over Time — -5.8; -4.0 score on a scale

Primary: Marijuana Abstinence (2 Weeks or Greater) — 72.5; 68.6; 45.1 percentage of participants

Primary: Number of Participants Who Remain in the Study — 9; 1 Participants

Primary: Dronabinol Exposure — 7.0; 5.6; 5.1; 5.0 nM*h — p=>0.05

Primary: Treatment Engagement — 78; 64; 109; 92 Participants — p=0.5340

Primary: Recruitment — 96 Participants

Primary: Perceived Acceptability — 4.3 Scale points